5-Amino-1MQ Research Guide
A small-molecule inhibitor of the enzyme NNMT, not a peptide. Covers the cell and mouse research on NNMT, NAD+ and metabolism.
What is 5-Amino-1MQ?
5-Amino-1MQ (5-amino-1-methylquinolinium) is a small molecule, not a peptide. It belongs to a methylquinolinium series of inhibitors of nicotinamide N-methyltransferase (NNMT), an enzyme found in the cytosol of cells (Neelakantan et al., 2018).
In cell assays, compounds from this series crossed membranes by both passive and active transport. They also proved selective: they did not inhibit related S-adenosylmethionine-dependent methyltransferases or the enzymes of the NAD+ salvage pathway that were tested (Neelakantan et al., 2018).
Research areas studied
The findings below come from cell, animal and published clinical research. They describe what studies have examined and reported, not effects of any research material.
Why NNMT is a research target
NNMT methylates nicotinamide (vitamin B3) using S-adenosylmethionine (SAM) as the methyl donor. A 2014 study reported that NNMT expression is increased in white adipose tissue and liver of obese and diabetic mice, and that knocking Nnmt down in those tissues protected mice against diet-induced obesity by raising cellular energy expenditure. The same work linked NNMT to SAM and NAD+ levels, histone methylation and polyamine flux (Kraus et al., 2014).
Cell studies
In cultured adipocytes, methylquinolinium NNMT inhibitors reduced the NNMT reaction product 1-methylnicotinamide, increased intracellular NAD+ and SAM, and suppressed lipogenesis (Neelakantan et al., 2018).
Animal studies
In diet-induced obese mice on a high-fat diet, a potent inhibitor from the series reduced body weight and white adipose mass, decreased adipocyte size and lowered plasma total cholesterol, without changing total food intake (Neelakantan et al., 2018). In 24-month-old mice after an experimental muscle injury, NNMT inhibitor administration was associated with more muscle stem cell proliferation and fusion, larger regenerating myofibers and greater contractile force than in controls (Neelakantan et al., 2019). A 2022 study combined 5-amino-1-methylquinolinium with a switch to a low-fat diet in obese mice and reported a cecal microbiome pattern distinct from that of the vehicle groups (Dimet-Wiley et al., 2022).
Human research and regulatory status
We found no published human clinical trials of 5-Amino-1MQ in our PubMed review (October 2026), and no regulatory approval in the sources reviewed. Most of the findings above come from a single research group, and results in rodents and cultured cells do not establish effects in people.
Storage and handling
Like most research compounds, 5-Amino-1MQ is normally supplied for laboratory use as a lyophilized (freeze-dried) powder in a sealed vial. Check the label and the batch COA for the exact form of your lot. Zero Zero Collection recommends keeping vials refrigerated at 2 to 8 ยฐC and protected from light, as stated on every product page. Let a refrigerated vial reach room temperature before opening it so moisture does not condense on the powder.
When a lab reconstitutes lyophilized material, standard practice is to add a sterile diluent such as bacteriostatic water slowly down the inside wall of the vial, then swirl gently rather than shake. The volume depends on the concentration a protocol calls for, so follow your own lab’s validated method. Label the vial with the date, keep reconstituted material refrigerated, and follow your institution’s guidance on how long a solution stays usable.
Quality and COA
Every Zero Zero Collection product page has a View COA link. Certificates of analysis come from independent third-party testing by Freedom Diagnostics and are posted on our Quality page where available. A COA reports what the testing lab measured for one specific batch, so match the lot number on your vial to the certificate. Our FAQ explains how to read a COA.
5-Amino-1MQ FAQ
Is 5-Amino-1MQ a peptide?
No. It is a small molecule, 5-amino-1-methylquinolinium. It is included in our research guides because it is studied alongside metabolic research peptides.
What does 5-Amino-1MQ inhibit?
It is studied as an inhibitor of nicotinamide N-methyltransferase (NNMT), the enzyme that methylates nicotinamide using S-adenosylmethionine.
Has 5-Amino-1MQ been studied in humans?
We found no published human clinical trials in our October 2026 PubMed review. The published research uses cell and mouse models.
References
- Neelakantan H, Vance V, Wetzel MD, et al. (2018). Biochem Pharmacol. PubMed 29155147
- Kraus D, Yang Q, Kong D, et al. (2014). Nature. PubMed 24717514
- Neelakantan H, Brightwell CR, Graber TG, et al. (2019). Biochem Pharmacol. PubMed 30753815
- Dimet-Wiley A, Wu Q, Wiley JT, et al. (2022). Sci Rep. PubMed 35013352
For research use only. Not for human consumption. This guide summarizes published scientific literature for laboratory research context. It is not medical advice, dosing guidance or a claim of safety or effectiveness for any use in people or animals.